This program has a clinical focus.
- Intended Audience: Pharmacists interested associated with the Advent Health Residency Program
- Universal Activity Number: 0012-0000-22-030-L99-P
- Contact Hours: 1.0 General hours of ACPE continuing education for pharmacists
- Program Fees: Complimentary for pharmacists associated with the Advent Health Residency Program
- UAN Release Date: 07/01/2022
- UAN Expiration Date: 06/30/2023
- Activity Type: Knowledge
- Program Support: No outside financial support was provided.
At the completion of this activity, the participant will be able to:
- Discuss a novel, controversial, or cutting-edge therapeutic topic used by pharmacists at a tertiary care health system.
- Review and analyze current literature related to pharmacotherapy and disease state management.
- Describe pertinent pharmacology and pharmacokinetics of medications utilized in disease state management.
- Demonstrate narratively how the new pharmacotherapeutic information will be applied to pharmacy practice at a tertiary care health system.
Requirements for Successful Course Completion
Attendance at the RSS Grand Rounds presentation and submit an evaluation within 15 days of the presentation.
Schedule of Activities
|Title||Presenter||Date and Time|
|Outpatient Treatment Options for COVID-19||Myla Nguyen||October 19, 2022
|Treatment options for GIB in LVAD patients||Jessica Behnam||October 25, 2022|
|Toxicological Emergencies in Pediatrics||Rosie Nagy||November 3, 2022|
|Management controversies of acute agitation in the ED||Patrick Funderburk||November 8. 2022|
|Diabetic Kidney Disease||Amber Johnson||November 9, 2022|
|Updates in HER2 Positive Breast Cancer Treatment||Alexis Ertle||November 10, 2022|
|Novel Therapies in ALL||Ariana Terravecchia||November 15, 2022|
|Controversies in TXA utilization||Yeji Lee||November 29. 2022|
|Gold 2022 Guideline Updates||Sandy Louka||December 16, 2022|
|GNR Bacteremia Controversies||Emma Ballantyne||December 20, 2022|
|Submersion injuries||Taylor Vandenberg||December 22, 2022|
|Use of Direct Oral Anticoagulants in Cirrhosis||Maha Fansa||January 3, 2023|
|Burnout and early departure in clinical pharmacists||Gabriella Perez||January 10, 2023|
|beta watch yo self: Beta-lactam induced neurotoxicity||Olivia Funk||January 12, 2023|
|CC OB||Michelle Dillon||January 17, 2023|
|TBD||Jose Lugo-Martinez||January 18, 2023|
|Glycemic mgmt in the critically/acutely ill patients||Jennifer Wilson||January 24, 2023|
|Sleep in the ICU||Emily Bennett||January 31, 2023|
|Updates of HF Guidelines - Improving GDTM - Utilization of ARNI and SGLT2i||Keaton Kaplan||February 1, 2023|
|Review of oncologic emergienes (FN, TLS, Hypercalcemia etc)||Rebecca Falter||February 2, 2023|
|Clostridium difficile Infection - A Review of 2021 Guideline Updates from IDSA and ACG||Yalda Saba||February 8, 2023|
|Ocular emergencies- intraocular pressure management/infection/exposures||Maitri Patel||February 21, 2023|
|Antithrombotics in TAVR/TAVI||Alexandra Cunha||February 23, 2023|
|IV Line Med Care: "Midline Crisis"||Renee Caneus||February 27, 2023|
|Blood pressure managemnt in neuro ICU||Caitlyn Lawrence||February 28, 2023|
|ACEI related Angioedema: What options do we have||Ashley Guzman Melero||March 1, 2023|
|Review of non-malignant heme type topics (hemophilia, sickle cell, ITP/TTP/HUS, etc)||Cheng Ieng Wong||March 2, 2023|
|2022 Heart Failure Guideline Update||Alexandra Cruz Pabon||March 9, 2023|
|TBD||Clint||March 13, 2023|
|Biomarkers for the detection and targeted management of rejection after transplantation||Brianna North||March 14, 2023|
|Management of Stenotrophomonas maltophilia infections – should TMP/SMX be considered first line||Jackie Espinoza-Ramirez||March 15, 2023|
|TBD||Nahla Hachmi||March 22, 2023|
|Phenobarbital for AWS||Lindsey Selph||March 23, 2023|
|Atrial fibrillation in critically ill patients||Brittany Allison||March 28, 2023|
|Controversies and Challenges of *MONA* in ACS||Dakota Manford||March 29, 2023|
|TBD||Rianna Rea||April 3, 2023|
|Long acting injectables for psychiatric patients||Mackenzie Walker||April 4, 2023|
|Dual therapy for MRSA Bacteremia/endocarditis – is two better than one?||Reginald Leandre||April 5, 2023|
|Nerve blocks vs systemic medications in the ED- local anesthetics and role of Exparel?||Nicholas Hammond||April 6, 2023|
|Pharmacist Guide to the Management of Potential Organ Donation in the ICU||Evesha Bryan||April 10, 2023|
|TBD||Carolyn Cooley||April 12, 2023|
|TBD||Parminder Kaur||April 17, 2023|
|Serotonin Syndrome Risks, Diagnosis and Management||Nhi Tran||May 3, 2023|
|Bringing History to the Mystery: ACLS Medications||Christian Cayabyab||June 16, 2023|
The above speakers and respective reviewers and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
Please review the resources below before registering for the course.
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.